IFNA1 and thymoma: Considering the risk of autoantibody production related to thymoma, we demonstrated the presence of autoantibodies neutralizing 1 ng/mL IFN-α and anti-IFN-ω autoantibodies in the patient (not in the daughter), even 6 months after thymectomy (Figure 2D).